Vanguard Personalized Indexing Management
TECH icon

Vanguard Personalized Indexing Management’s Bio-Techne TECH Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
22,626
-10,718
-32% -$579K 0.01% 749
2026
Q1 		$1.74M Sell
33,344
-1,497
-4% -$89.9K 0.02% 662
2025
Q4 		$2.05M Buy
34,841
+3,231
+10% +$196K 0.02% 590
2025
Q3 		$1.76M Buy
31,610
+1,342
+4% +$71.9K 0.02% 637
2025
Q2 		$1.56M Buy
30,268
+11,992
+66% +$603K 0.02% 665
2025
Q1 		$1.07M Sell
18,276
-2,927
-14% -$198K 0.02% 750
2024
Q4 		$1.53M Buy
21,203
+4,144
+24% +$304K 0.02% 572
2024
Q3 		$1.36M Buy
17,059
+738
+5% +$55.5K 0.02% 618
2024
Q2 		$1.17M Buy
16,321
+2,390
+17% +$176K 0.02% 606
2024
Q1 		$981K Buy
13,931
+2,226
+19% +$159K 0.02% 671
2023
Q4 		$903K Buy
11,705
+2,958
+34% +$195K 0.02% 709
2023
Q3 		$595K Sell
8,747
-1,704
-16% -$135K 0.02% 805
2023
Q2 		$853K Buy
10,451
+1,403
+16% +$113K 0.03% 640
2023
Q1 		$671K Sell
9,048
-4,180
-32% -$322K 0.02% 729
2022
Q4 		$1.1M Sell
13,228
-2,900
-18% -$230K 0.05% 471
2022
Q3 		$1.15M Buy
16,128
+5,856
+57% +$506K 0.05% 423
2022
Q2 		$890K Buy
10,272
+2,396
+30% +$225K 0.04% 520
2022
Q1 		$853K Buy
7,876
+1,032
+15% +$106K 0.04% 540
2021
Q4 		$885K Buy
6,844
+512
+8% +$62.8K 0.05% 457
2021
Q3 		$767K Buy
6,332
+1,136
+22% +$138K 0.07% 318
2021
Q2 		$585K Sell
5,196
-680
-12% -$71.6K 0.06% 410
2021
Q1 		$561K Buy
5,876
+1,168
+25% +$107K 0.08% 286
2020
Q4 		$374K Buy
4,708
+292
+7% +$21.1K 0.08% 290
2020
Q3 		$273K Buy
4,416
+136
+3% +$8.85K 0.08% 322
2020
Q2 		$283K Buy
+4,280
New +$256K 0.13% 203

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Personalized Indexing Management's TECH Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Bio-Techne (TECH) stake by 32% in Q2 2026, selling an estimated $579K and leaving 22,626 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #749.

Vanguard Personalized Indexing Management first reported a position in TECH in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.05M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Vanguard Personalized Indexing Management held 22,626 shares of Bio-Techne worth $1.6M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 10,718 Bio-Techne shares in Q2 2026, an estimated $579K.
  • Bio-Techne made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #749 holding.
  • Vanguard Personalized Indexing Management first reported a position in Bio-Techne in Q2 2020 and has held it in 25 quarters since.
  • Vanguard Personalized Indexing Management's Bio-Techne position peaked at $2.05M in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.